Three experts on bone health explain why your bone density is important, and the types of exercise that can help.

Osteoporosis, often called a silent disease, weakens bones and increases the risk of fractures, making it a leading cause of disability among the elderly. In the Philippines, millions are affected, ...

The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).

The US Food and Drug Administration (FDA) has approved Celltrion’s biosimilars referencing Amgen’s bone disease therapy ...

Osteoarthritis cases and disability among postmenopausal women have risen significantly over the past three decades, driven ...

On March 3, 2025, the FDA approved Celltrion’s denosumab biosimilars, STOBOCLO® (denosumab-bmwo; 60 mg/mL injection) and OSENVELT® (denosumab-bmwo; ...

The Philippine Academy of Rehabilitation Medicine (PARM) celebrated its 50th anniversary during its 35th annual convention, ...

The Philippine Academy of Rehabilitation Medicine (PARM) underscored the Philippines’ role as a hub for world-class rehabilitation medicine and its contributions to the global medical community.

The FDA has approved 2 biosimilars, denosumab-bmwo (CT-P41; Stoboclo) and (Osenvelt), for all indications of their respective reference products (Prolia) and (Xgeva), Celltrion stated in a news ...

The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).

Vitamins and minerals are key to helping us stay healthy. Researchers at Osteoporosis International and elsewhere have looked ...